Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere Shortening | 2 | 2021 | 34 | 0.770 |
Why?
|
| Sirtuins | 1 | 2019 | 20 | 0.610 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 898 | 0.470 |
Why?
|
| Mitochondria | 4 | 2017 | 747 | 0.400 |
Why?
|
| Telomere | 3 | 2021 | 222 | 0.390 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 198 | 0.350 |
Why?
|
| Telomerase | 3 | 2019 | 168 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 763 | 0.290 |
Why?
|
| Chromatin | 2 | 2022 | 518 | 0.280 |
Why?
|
| Aging | 2 | 2012 | 1248 | 0.280 |
Why?
|
| Telomere Homeostasis | 2 | 2019 | 45 | 0.240 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 48 | 0.200 |
Why?
|
| Collagen Type VI | 1 | 2021 | 7 | 0.180 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 27 | 0.180 |
Why?
|
| Protein Subunits | 1 | 2021 | 171 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 133 | 0.170 |
Why?
|
| Cullin Proteins | 1 | 2020 | 14 | 0.170 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 204 | 0.160 |
Why?
|
| Hematopoiesis | 1 | 2021 | 224 | 0.160 |
Why?
|
| Fibrosis | 1 | 2021 | 421 | 0.160 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 4 | 0.150 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 34 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 207 | 0.150 |
Why?
|
| Claudins | 1 | 2018 | 31 | 0.150 |
Why?
|
| Muscle Proteins | 2 | 2018 | 407 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 54 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2021 | 3037 | 0.140 |
Why?
|
| Mitosis | 1 | 2018 | 196 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 246 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2011 | 169 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 846 | 0.140 |
Why?
|
| Glioblastoma | 2 | 2012 | 363 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 241 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 440 | 0.130 |
Why?
|
| Animals | 14 | 2021 | 34798 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 677 | 0.130 |
Why?
|
| Cell Movement | 2 | 2018 | 889 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 57 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2019 | 799 | 0.130 |
Why?
|
| Mice | 11 | 2021 | 18466 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4754 | 0.120 |
Why?
|
| Signal Transduction | 7 | 2021 | 4704 | 0.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 246 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 2057 | 0.110 |
Why?
|
| p21-Activated Kinases | 2 | 2018 | 56 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 729 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 604 | 0.100 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 1977 | 0.090 |
Why?
|
| Genes, Essential | 1 | 2012 | 43 | 0.090 |
Why?
|
| Genes, myc | 2 | 2022 | 103 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 1796 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2017 | 803 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3861 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 1035 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2012 | 526 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 197 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 129 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 396 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 397 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2011 | 462 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 224 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2508 | 0.070 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 22 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2020 | 2493 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 550 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 633 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 69 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2008 | 12 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2017 | 378 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2018 | 751 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 426 | 0.070 |
Why?
|
| Carcinogens | 1 | 2008 | 127 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1443 | 0.060 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 517 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 132089 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2648 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2010 | 1960 | 0.060 |
Why?
|
| Stem Cells | 1 | 2010 | 732 | 0.060 |
Why?
|
| Cyclophilin A | 1 | 2024 | 15 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1280 | 0.050 |
Why?
|
| Mutation | 1 | 2017 | 6228 | 0.050 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 61 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1378 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3681 | 0.050 |
Why?
|
| Apoptosis | 2 | 2021 | 1892 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2021 | 128 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 251 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 49 | 0.050 |
Why?
|
| Megakaryocytes | 1 | 2021 | 43 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 176 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 142 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 127 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 897 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2020 | 140 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 172 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 442 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 198 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 490 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 25 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 27 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2020 | 731 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 67 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 39 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 67 | 0.040 |
Why?
|
| Phenotype | 3 | 2017 | 4528 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 663 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 361 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 347 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 197 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 728 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 587 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1538 | 0.030 |
Why?
|
| DNA Damage | 2 | 2011 | 511 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 379 | 0.030 |
Why?
|
| Male | 3 | 2019 | 64967 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Proteogenomics | 1 | 2018 | 109 | 0.030 |
Why?
|
| Female | 3 | 2019 | 70695 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 126 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1730 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1422 | 0.030 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 270 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2017 | 255 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 3609 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1608 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 596 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 812 | 0.030 |
Why?
|
| Phosphonoacetic Acid | 1 | 2012 | 2 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 30 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 60 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2012 | 25 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 149 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 1078 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 1826 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 382 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 100 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1047 | 0.020 |
Why?
|
| Cardiac Volume | 1 | 2011 | 19 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 209 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 38 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2012 | 62 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 65 | 0.020 |
Why?
|
| Chloroquine | 1 | 2011 | 31 | 0.020 |
Why?
|
| Enzyme Reactivators | 1 | 2010 | 3 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 111 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 156 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 35 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 547 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 271 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 60 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 687 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 430 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 256 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 125 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 448 | 0.020 |
Why?
|
| Smell | 1 | 2010 | 131 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 615 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 589 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2010 | 149 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 349 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 514 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 161 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 469 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 52 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 684 | 0.020 |
Why?
|
| Epidermis | 1 | 2008 | 64 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 83 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 762 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 175 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 500 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1659 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 1647 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3351 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 3176 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 2957 | 0.010 |
Why?
|